Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Revista
País de afiliación
Intervalo de año de publicación
1.
Blood ; 107(1): 334-40, 2006 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-16141353

RESUMEN

Congenital dyserythropoietic anemia type I (CDA I) is a rare autosomal recessive disorder with ineffective erythropoiesis and iron overloading. More than 100 cases have been described, but with the exception of a report on a large Bedouin tribe, these reports include only small numbers of cases, and no data on the lifetime evolution of the disease are available. Since 1967, we have been able to follow 21 cases from 19 families for up to 37 years. Twenty-one patients with a confirmed diagnosis of CDA I exhibited chronic macrocytic anemia of variable severity, requiring regular red cell transfusions only in 2 individuals. Four developed gallstones before the age of 30 years. Fifteen of 16 cases alive at the time of analysis showed mutations of at least one allele from exons 6 to 28 within CDAN1. Iron overloading is to be expected in all patients. In 9 patients, iron depletion was started between the ages of 7 and 36 years. Splenectomy, which was performed in 7 patients, did not result in improvement of hemoglobin values. Five patients were treated with interferon alpha-2a, and all responded with a rise in hemoglobin concentration of between 25 and 35 g/L (2.5 and 3.5 g/dL) starting within 4 weeks.


Asunto(s)
Anemia Diseritropoyética Congénita , Adolescente , Adulto , Anemia Diseritropoyética Congénita/genética , Anemia Diseritropoyética Congénita/patología , Anemia Diseritropoyética Congénita/terapia , Anemia Macrocítica , Niño , Exones , Salud de la Familia , Femenino , Cálculos Biliares , Alemania/epidemiología , Glicoproteínas/genética , Humanos , Interferón alfa-2 , Interferón-alfa/uso terapéutico , Hierro/metabolismo , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Mutación , Proteínas Nucleares , Pronóstico , Proteínas Recombinantes , Esplenectomía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA